Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-22,500
Closed -$826K 2621
2017
Q3
$826K Buy
+22,500
New +$908K 0.01% 1377
2016
Q2
Sell
-80,600
Closed -$2.78M 2261
2016
Q1
$2.78M Buy
+80,600
New +$2.81M 0.02% 702
2015
Q4
Sell
-47,000
Closed -$1.84M 2392
2015
Q3
$1.84M Buy
+47,000
New +$1.86M 0.01% 926
2014
Q3
Sell
-100,000
Closed -$2.54M 2252
2014
Q2
$2.54M Buy
+100,000
New +$2.34M 0.02% 562
2013
Q4
Sell
-50,000
Closed -$1.03M 2043
2013
Q3
$1.03M Buy
+50,000
New +$1.06M 0.01% 894

Other funds holding HOLX

Jefferies Group's HOLX Position: Q3 2022 in Review

Jefferies Group increased its Hologic (HOLX) stake by 14,107% in Q3 2022, buying an estimated $4.79M and bringing the position to 69,614 shares worth $4.49M. The position accounts for 0.04% of the portfolio, ranked #370.

Jefferies Group first reported a position in HOLX in Q2 2013 and has held it in 29 quarters since. The position peaked at $9.96M in Q1 2022. 653 funds tracked by Wall St. Rank hold HOLX as of Q3 2022.

  • Jefferies Group held 69,614 shares of Hologic worth $4.49M as of Q3 2022.
  • Jefferies Group bought 69,124 Hologic shares in Q3 2022, an estimated $4.79M.
  • Hologic made up 0.04% of Jefferies Group's portfolio in Q3 2022, its #370 holding.
  • Jefferies Group first reported a position in Hologic in Q2 2013 and has held it in 29 quarters since.
  • Jefferies Group's Hologic position peaked at $9.96M in Q1 2022.
  • 653 funds tracked by Wall St. Rank held Hologic as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.